Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
116.3%
operating margin TTM
31.45%
revenue TTM
12.40 Million
revenue per share TTM
0.67$
valuation ratios | |
|---|---|
| pe ratio | 2.64 |
| peg ratio | 0.01 |
| price to book ratio | 2.03 |
| price to sales ratio | 3.12 |
| enterprise value multiple | 9.40 |
| price fair value | 2.03 |
profitability ratios | |
|---|---|
| gross profit margin | 91.39% |
| operating profit margin | 31.45% |
| pretax profit margin | 30.92% |
| net profit margin | 116.3% |
| return on assets | 61.78% |
| return on equity | 96.49% |
| return on capital employed | 20.45% |
liquidity ratios | |
|---|---|
| current ratio | 1.95 |
| quick ratio | 1.79 |
| cash ratio | 0.64 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 219.97 |
| operating cycle | 293.88 |
| days of payables outstanding | 61.41 |
| cash conversion cycle | 232.46 |
| receivables turnover | 4.94 |
| payables turnover | 5.94 |
| inventory turnover | 1.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.09 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.09 |
| interest coverage | 15.00 |
| cash flow to debt ratio | 1.99 |
cash flow ratios | |
|---|---|
| free cash flow per share | 4.28 |
| cash per share | 5.14 |
| operating cash flow per share | 4.28 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.99 |
| short term coverage ratios | 2.02 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) reported earnings?
Rigel Pharmaceuticals, Inc. (RIGL) published its most recent earnings results on 04-08-2026.
What is Rigel Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)'s trailing twelve months ROE is 96.49%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Rigel Pharmaceuticals, Inc. (RIGL) currently has a ROA of 61.78%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RIGL's net profit margin stand at?
RIGL reported a profit margin of 116.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RIGL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.95 in the most recent quarter. The quick ratio stood at 1.79, with a Debt/Eq ratio of 0.09.